retatrutide glp-1 gip glucagon agonist Targeting GLP-1, & GCG in Obesity and Type 2 Diabetes Research What GLP‑3 Really Is: Retatrutide

The study assessed whether GLP-1 receptor agonists, a class of medicines widely used to treat type 2 diabetes (T2DM) and obesity, were associated with long-term breast cancer outcomes

Gut microbiota composition (including Firmicutes , Bacteroidetes , Akkermansia , and Bifidobacterium ) influences host metabolism by producing short-chain fatty acids (SCFAs), generating secondary bile acids, modulating immune and inflammatory pathways, and stimulating GLP-1 secretion from intestinal L-cells

There are several GLP-1 receptor agonists which have been studied as potential treatments and potential disease modifiers for Parkinsons disease

Lancet 397(10278):971984 [DOI] [PubMed] [Google Scholar] 20.Shi I, Khan SS, Yeh RW, Ho JE, Dahabreh IJ, Kazi DS (2025) Semaglutide Eligibility Across All Current Indications for US Adults

The survey found 82% of poll participants had at least a little knowledge about the drugs, and 32% said they had heard a lot about them

GLP-1RAs also alleviate high-sugar-induced dysfunction in endothelial progenitor cells through the SDF-1/CXCR7-AMPK/p38-MAPK/IL-6 signaling axis (91)